Microbot Medical company info

What does Microbot Medical do?
Microbot Medical (NASDAQ:MBOT) is a pioneering company focused on the design and development of robotic technologies aimed at advancing minimally invasive surgeries. Their operations span across creating innovative solutions that could drastically improve surgical outcomes and patient recovery times. Microbot Medical's projects are largely centered around their proprietary technology platforms, which include micro-robotics, with the aim of addressing unmet needs in medical procedures. These endeavors are aligned with their objectives to enhance surgical precision, reduce risks associated with traditional surgical methods, and ultimately improve the quality of life for patients. The company's commitment to research and development in the medical field showcases its dedication to pushing the boundaries of medical science and technology.
Microbot Medical company media
Company Snapshot

Is Microbot Medical a public or private company?

key
Ownership
Public

How many people does Microbot Medical employ?

people
Employees
22

What sector is Microbot Medical in?

pie chart
Sector
Health Care

Where is the head office for Microbot Medical?

location pin
Head Office
Newark, United States

What year was Microbot Medical founded?

founded flag
Year Founded
1988
What does Microbot Medical specialise in?
/Robotic Technology /Minimally Invasive /Medical Procedures /Self-Cleaning Shunts /Cardiovascular Solutions /Early Detection

What are the products and/or services of Microbot Medical?

Overview of Microbot Medical offerings
LIBERTY® Robotic Surgical System: This is the core product of Microbot Medical. It's a single-use endovascular robotic system designed for minimally invasive therapy delivery directly on the heart surface.
Minimally Invasive Therapy Delivery: The LIBERTY® system allows for the delivery of various therapeutic interventions directly to the heart surface or within other vascular structures, such as ablation for atrial fibrillation or targeted drug delivery.
Endovascular Robotic Surgery: Microbot Medical's technology aims to revolutionize endovascular procedures through the LIBERTY® system, offering greater precision, reduced radiation exposure, and improved accessibility compared to traditional methods.
Remote-Controlled Surgery: The LIBERTY® system can be controlled remotely by a surgeon, potentially enabling tele-surgery and improved access to specialized care.
Clinical Development and Regulatory Affairs: Microbot Medical is actively involved in the clinical development and regulatory approval process for the LIBERTY® system, working towards obtaining FDA clearance for its use in human patients.
Partnerships and Collaborations: Microbot Medical collaborates with leading medical institutions and organizations to advance the development and evaluation of the LIBERTY® system, fostering innovation and expanding its reach.

Who is in the executive team of Microbot Medical?

Microbot Medical leadership team
  • Mr. Harel  Gadot
    Mr. Harel Gadot
    Co-Founder, President, CEO & Chairman
  • Mr. Yoseph  Bornstein
    Mr. Yoseph Bornstein
    Co-Founder & Independent Director
  • Ms. Rachel  Vaknin
    Ms. Rachel Vaknin
    Chief Financial Officer
  • Dr. Simon  Sharon MBA, MSc
    Dr. Simon Sharon MBA, MSc
    CTO & GM of Microbot Israel
  • Dr. Juan  Diaz-Cartelle
    Dr. Juan Diaz-Cartelle
    Chief Medical Officer